Aelan -Oncology Enabling Technology

SHARE

Cancer survival rates decrease with age, in part because the efficacy of cancer therapies decline for older people.

Most popular related searches

Chemotherapy and radiotherapy wreak havoc on the immune system, cause a buildup of cellular waste in remaining tissue and kill healthy and cancerous cells alike, leaving a residue that needs to be either removed from the body or efficiently restored to the original biological function.

Aelan technology addresses this by boosting the efficiency of DNA repair in critical cells following cancer treatment. Aelan is developing products that promote organ and tissue homeostasis by inducing cell proliferation, angiogenesis, interactions with the immune system and protection against cell death and senescence.